Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rowan T Chlebowski

Showing results (311-320 of 366) with videos related to

Pageof 37
Sort By:
American Journal of Epidemiology|May 2, 2008
Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational studyRoss L Prentice, Rowan T Chlebowski, Marcia L Stefanick, et al.
Journal of the Academy of Nutrition and Dietetics|February 23, 2024
Dietary Intervention Favorably Influences Physical Functioning: The Women's Health Initiative Randomized Dietary Modification TrialRowan T Chlebowski, Aaron K Aragaki, Kathy Pan, et al.
Cancer|May 13, 2024
Breast cancer incidence and mortality by metabolic syndrome and obesity: The Women's Health InitiativeRowan T Chlebowski, Aaron K Aragaki, Kathy Pan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2017
Low-Fat Dietary Pattern and Breast Cancer Mortality in the Women's Health Initiative Randomized Controlled TrialRowan T Chlebowski, Aaron K Aragaki, Garnet L Anderson, et al.
Journal of the National Cancer Institute|August 17, 2010
Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trialRowan T Chlebowski, Garnet L Anderson, JoAnn E Manson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 10, 2014
Nutrition and physical activity cancer prevention guidelines, cancer risk, and mortality in the women's health initiativeCynthia A Thomson, Marjorie L McCullough, Betsy C Wertheim, et al.
International Journal of Cancer|August 24, 2017
Methodological considerations for disentangling a risk factor's influence on disease incidence versus postdiagnosis survival: The example of obesity and breast and colorectal cancer mortality in the Women's Health InitiativeElizabeth M Cespedes Feliciano, Ross L Prentice, Aaron K Aragaki, et al.
International Journal of Cancer|September 6, 2018
Estrogen metabolism in menopausal hormone users in the women's health initiative observational study: Does it differ between estrogen plus progestin and estrogen alone?Roni T Falk, JoAnn E Manson, Vanessa M Barnabei, et al.
Cancer|January 21, 2021
Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health InitiativeYuan Yuan, Kathy Pan, Joanne Mortimer, et al.
Nutrition and Cancer|July 22, 2011
The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health Initiative (WHI) calcium plus vitamin D randomized clinical trialRobert L Brunner, Jean Wactawski-Wende, Bette J Caan, et al.
Pageof 37

Showing results (311-320 of 366) with videos related to

Sort By:
Pageof 37
American Journal of Epidemiology|May 2, 2008
Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational studyRoss L Prentice, Rowan T Chlebowski, Marcia L Stefanick, et al.
Journal of the Academy of Nutrition and Dietetics|February 23, 2024
Dietary Intervention Favorably Influences Physical Functioning: The Women's Health Initiative Randomized Dietary Modification TrialRowan T Chlebowski, Aaron K Aragaki, Kathy Pan, et al.
Cancer|May 13, 2024
Breast cancer incidence and mortality by metabolic syndrome and obesity: The Women's Health InitiativeRowan T Chlebowski, Aaron K Aragaki, Kathy Pan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2017
Low-Fat Dietary Pattern and Breast Cancer Mortality in the Women's Health Initiative Randomized Controlled TrialRowan T Chlebowski, Aaron K Aragaki, Garnet L Anderson, et al.
Journal of the National Cancer Institute|August 17, 2010
Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trialRowan T Chlebowski, Garnet L Anderson, JoAnn E Manson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 10, 2014
Nutrition and physical activity cancer prevention guidelines, cancer risk, and mortality in the women's health initiativeCynthia A Thomson, Marjorie L McCullough, Betsy C Wertheim, et al.
International Journal of Cancer|August 24, 2017
Methodological considerations for disentangling a risk factor's influence on disease incidence versus postdiagnosis survival: The example of obesity and breast and colorectal cancer mortality in the Women's Health InitiativeElizabeth M Cespedes Feliciano, Ross L Prentice, Aaron K Aragaki, et al.
International Journal of Cancer|September 6, 2018
Estrogen metabolism in menopausal hormone users in the women's health initiative observational study: Does it differ between estrogen plus progestin and estrogen alone?Roni T Falk, JoAnn E Manson, Vanessa M Barnabei, et al.
Cancer|January 21, 2021
Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health InitiativeYuan Yuan, Kathy Pan, Joanne Mortimer, et al.
Nutrition and Cancer|July 22, 2011
The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health Initiative (WHI) calcium plus vitamin D randomized clinical trialRobert L Brunner, Jean Wactawski-Wende, Bette J Caan, et al.
Pageof 37